Cambridge Nutritional Sciences plc
CNSL.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -7.9% | 1.5% | -14.6% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 61.8% | 60.1% | 60.1% | 56.5% |
| EBITDA | -£0 | £0 | £0 | £0 |
| % Margin | -1.7% | 49.5% | 2.9% | 5.9% |
| Net Income | -£0 | £0 | -£0 | £0 |
| % Margin | -10.3% | 42% | -4.7% | 7.6% |
| EPS Diluted | -0.002 | 0.007 | -0.001 | 0.002 |
| % Growth | -123% | 1,025% | -150% | – |
| Operating Cash Flow | -£0 | £0 | -£0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | £0 | -£0 | £0 |